Spago Nanomedical strengthens management with Head of CMC & Supply

MARKN.

Spago Nanomedical AB (publ) today announced the appointment of Birgitta Rembratt Svensson as Head of CMC & Supply. Birgitta, an experienced CMC project manager with several leading positions at development and commercial stage pharmaceutical companies, will join Spago Nanomedical on June 1 and serve as a member of the management team.

“I am very pleased to welcome Birgitta to Spago Nanomedical. As Head of CMC & Supply, Birgitta’s broad managerial and technical experience in regulatory CMC and pharmaceutical development, both clinical and non-clinical, will be of great importance in advancing our pipeline. Her experience from managing contract manufacturers, ensuring all operations meet delivery and quality standards, will also play an important role as we take our lead program Tumorad into the next phase,” said Mats Hansen, CEO of Spago Nanomedical.

Birgitta joins from the Danish commercial stage pharmaceutical company MC2 Therapeutics where she was CMC Project Manager since 2021. Previous positions include e.g. Head of Development at Sever Pharma Solutions AB and Bioglan AB, respectively. Birgitta holds a Ph. D. in physical chemistry and a M. Sc. in chemistry from Lund University.

Datum 2024-04-16, kl 10:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!